http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Managing human capital for innovative activities in Indonesian herbal medicine firms
Erman Aminullah,Wati Hermawati,Trina Fizzanty,Qinan M. B. Soesanto 기술경영경제학회 2017 ASIAN JOURNAL OF TECHNOLOGY INNOVATION Vol.25 No.2
This paper attempts to explain human capital enhancement (HCE)practices in upgrading human skills, knowledge and ability,specifically (i) how firms’ internal upgrading mechanisms areimplemented and (ii) how firms enhance human capital throughinteractions with external parties. Through case studies ofIndonesian herbal medicine firms, this study reveals that HCE forinnovative activities in herbal medicine firms occurred throughinnovative learning – by using and interacting. Companies showlearning by using traditional herbal ingredients to redesigninnovative products; managing continuously internal learning byinteracting across functional teams to create new, innovativeproducts; and managing external learning by interacting withexternal parties in the search for new, innovative products. Theeffective use of internal and external sources of innovation iscoordinated by, respectively, top management direction inside thecompany without research and development (R&D); managers ofcross-functional teams within the company with in-house R&Dactivities; and top-level management meetings within thecompany with limited R&D activities.
Technological convergence in Indonesian firms: cases of biobased chemical product innovation
Erman Aminullah,Trina Fizzanty,Galuh S. Indraprahasta,Indri J. Asmara 기술경영경제학회 2015 ASIAN JOURNAL OF TECHNOLOGY INNOVATION Vol.23 No.-
This paper attempts to explain how technological convergence has occurred in Indonesianchemical firms. Viewed from the sectoral innovation system, the enabling factors ofbiobased chemical products innovation are the availability of scientist and researcher atuniversity and research collaboration in company. The ways forward to promotetechnological convergence in Indonesian biobased chemical firms are to enhance its internaland external R&D capacity by supporting chemical firms to interact with public R&D anduniversity. To enable the biobased chemical sector to take the opportunities to grow throughtechnological convergence, the Indonesian government policy should (i) provide strongsupport for research, development, and commercialisation of innovative biobased products,and incentives for pioneering the commercial production and (ii) facilitate the biobasedchemical value chains to develop by supporting biobased chemical investment, theadvocation of using biobased chemical products in society, and limiting of using petroleumbasedchemical products in the market.
STI policy and R&D governance for the attainment of SDGs: envisioning the Indonesia’s future
Aminullah Erman 기술경영경제학회 2020 ASIAN JOURNAL OF TECHNOLOGY INNOVATION Vol.28 No.2
This paper is a system analysis of STI policy and R&D governance for the attainment of SDGs. The objective was to articulate a holistic model of STI policies and R&D governance for meeting the SDGs’ agenda 2030’s. It was analysed by using the model of STI policy and R&D governance to attain SDGs. The model dealt with: i) STI policy direction by the function of STI policy council, which sets STI policy directions and resources allocation for national goals, ii) the instrument of STI policy by the function of integrating body for R&D governance, which executes the coordinated and synergized national R&D program and projects involving across sectoral ministries/institutions. The model implementation would contribute to: i) STI-based economy in the long run, where STI-based industrialization should be pursued by the application of industrial policy to promote innovative industries driven by R&D in strategic area focus; and ii) meeting the SDGs’ targets through STI, where STI policy, organizational coordination and R&D governance for economic prosperity should shift towards transformative innovation policy, which is inspired by social ecology and environmental protection. The leverage factor for effective STI policy and productive R&D governance in Indonesia is the availability of highly qualified researchers.